Solventum Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	-	8,197	8,130	8,171
Revenue Growth (YoY)	-	0.82%	-0.50%	-
Cost of Revenue	-	3,504	3,435	3,248
Gross Profit	-	4,693	4,695	4,923
Selling, General & Admin	-	2,243	2,235	2,278
Research & Development	-	758	767	766
Operating Expenses	-	3,001	3,002	3,044
Operating Income	-	1,692	1,693	1,879
Other Expense / Income	-	25	1	-3
Pretax Income	-	1,667	1,692	1,882
Income Tax	-	321	349	422
Net Income	-	1,346	1,343	1,460
Net Income Growth	-	0.22%	-8.01%	-
Shares Outstanding (Basic)	173	172	-	-
Free Cash Flow	-	1,625	1,428	1,925
Free Cash Flow Per Share	-	9.42	-	-
Gross Margin	-	57.25%	57.75%	60.25%
Operating Margin	-	20.64%	20.82%	23.00%
Profit Margin	-	16.42%	16.52%	17.87%
Free Cash Flow Margin	-	19.82%	17.56%	23.56%
Effective Tax Rate	-	19.26%	20.63%	22.42%
EBITDA	-	2,228	2,270	2,479
EBITDA Margin	-	27.18%	27.92%	30.34%
Depreciation & Amortization	-	561	578	597
EBIT	-	1,667	1,692	1,882
EBIT Margin	-	20.34%	20.81%	23.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).